SpectraScience has acquired the assets of Applied Materials-backed oncology diagnostics technology developer Oncoscope for an undisclosed sum.
Medical device maker SpectraScience has acquired the assets of Oncoscope, a US-based optical imaging system developer backed by industrial manufacturing equipment provider Applied Materials, for an undisclosed amount.
Oncoscope is developing technology that uses scattered white light to detect pre-cancerous epithelial tissue, and the first target indication was for Barrett’s Esophagus, a precursor for cancer of the oesophagus.
SpectraScience, which produces spectrophotometry systems that test whether tissue is normal, pre-cancerous or cancerous, will add Oncoscope’s technology to its own,…